“…Conventional approaches to drug exploration and advancements are strenuous, sluggish, and expensive [ 31 ]. To reduce these drawbacks, in-silico methods can be employed as an alternative approach thereby facilitating numerous discoveries [ 28 , 29 , 30 , 32 , 33 , 34 , 35 ]. These methods are dynamic, rapid, and cost-effective than traditional drug discovery and development methods [ 31 ].…”